Thyrocare Technologies Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

We wish to inform you that as already intimated to you in our letter dated July 27, 2022, a conference call for the Indian and Overseas analysts / investors took place at 9.00 a.m. today, to discuss the Company's financial results for Quarter ended June 30, 2022. Mr. Rahul Guha, Managing Director & Chief Executive Officer and Mr. Sachin Salvi, Chief Financial Officer, represented the Management. We confirm that no Unpublished Price Sensitive Information was shared / discussed in the call. We are forwarding audio recording of the conference call. We have also uploaded it on our website. We will be forwarding the transcript shortly.